Miltefosine Treatment of Cutaneous Leishmaniasis.

Simple item page
dc.contributor.authorSoto, Jaime A
dc.contributor.authorBerman, Jonathan D
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-24T15:04:23Z
dc.date.available2026-03-24T15:04:23Z
dc.date.issued2021
dc.descriptionVol. 73, No. 7, pp. e2463-e2464
dc.description.sponsorshipFundación Nacional de Dermatología and Hospital Dermatológico de Jorochito, Santa Cruz, Bolivia. | Fast-Track Drugs and Biologics LLC, North Potomac, Maryland, USA.
dc.identifier.doi10.1093/cid/ciaa1461
dc.identifier.issn1537-6591
dc.identifier.otherPMID:33128373
dc.identifier.urihttps://doi.org/10.1093/cid/ciaa1461
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/101038
dc.language.isoeng
dc.relation.ispartofClinical infectious diseases : an official publication of the Infectious Diseases Society of America
dc.sourcePubMed
dc.subjectcutaneous leishmaniasis
dc.subjectefficacy
dc.subjectmiltefosine
dc.subjecttolerance
dc.titleMiltefosine Treatment of Cutaneous Leishmaniasis.
dc.typeArtículo Científico Publicado

Files

Collections

Artículo Científico Publicado